Product
Afabicin
1 clinical trial
1 indication
Indication
Bone or Joint InfectionClinical trial
Randomized Open-label Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of Afabicin IV/Oral in the Treatment of Patients With Bone or Joint Infection Due to StaphylococcusStatus: Recruiting, Estimated PCD: 2026-12-01